Citation:Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, et al 2012

From Cancer Guidelines Wiki

Citation


Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, et al. Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer. Lung Cancer 2012 Sep;77(3):532-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22672970.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, et al 2012What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?Professor David Ball MB BS, MD, FRANCZRcompleted
Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, et al 2012 1What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?Dr Shawgi Sukumarancompleted
Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, et al 2012 2What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?Professor David Ball MB BS, MD, FRANCZRcompleted
Price A, Yellowlees A, Keerie C, Russell S, Faivre-Finn C, Gilligan D, et al 2012 3What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?Associate Professor Christos Karapetiscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage II NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the role of chemotherapy when added to radiotherapy in the treatment of inoperable stage I NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the best practice radiotherapy approach in patients with stage I inoperable NSCLC?
  2. What is the best practice radiotherapy approach in patients with stage II inoperable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Price_A,_Yellowlees_A,_Keerie_C,_Russell_S,_Faivre-Finn_C,_Gilligan_D,_et_al_2012&oldid=83145"